Cargando…
Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis
BACKGROUND: Mutation-caused loss-of-function of factors involved in DNA damage response (DDR) is responsible for the development and progression of ~20% of prostate cancer (PCa). Some mutations can be used in cancer risk assessment and informed treatment decisions. METHODS: Target capture-based deep...
Autores principales: | Tang, Tang, Wang, Lin-ang, Wang, Peng, Tong, Dali, Liu, Gaolei, Zhang, Jun, Dai, Nan, Zhang, Yao, Yuan, Gang, Geary, Kyla, Zhang, Dianzheng, Liu, Qiuli, Jiang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649358/ https://www.ncbi.nlm.nih.gov/pubmed/33194641 http://dx.doi.org/10.3389/fonc.2020.564694 |
Ejemplares similares
-
Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
por: Hu, Zhe-Yu, et al.
Publicado: (2020) -
HIF2A germline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma
por: Liu, Qiuli, et al.
Publicado: (2017) -
Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
por: Liu, Qiuli, et al.
Publicado: (2017) -
A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy
por: Liu, Qiuli, et al.
Publicado: (2018) -
PALB2 (partner and localizer of BRCA2)
por: Hanenberg, Helmut, et al.
Publicado: (2018)